Non-invasive imaging biomarkers for liver steato- sis in non-alcoholic fatty liver disease: present and future

키워드

참고문헌 (15)

1. Setiawan VW, "Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups : The multiethnic cohort", Hepatology, 64, pp.1969~1977 (2016)
2. Noureddin M, "Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018transient elastography data and application of machine learning", Hepatol Commun, 6, pp.1537~1548 (2022)
3. Sumida Y, "Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease", nonalcoholic steatohepatitis, 2014, pp.20, 475~485
4. Brunt EM, "Complexity of ballooned hepatocyte feature recognition : Defining a training atlas for artificial intelligence-based imaging in NAFLD", J Hepatol, 76, pp.1030~1041 (2022)
5. Bravo AA, "Liver biopsy", N Engl J Med, 344, pp.495~500 (2001)
6. Asako Nogami, "Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future", Clinical and Molecular Hepatology, 29, pp.123~135 (2023), 대한간학회
7. Noureddin M, "Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials", Hepatology, 58, pp.1930~1940 (2013)
8. Newsome PN, "FibroScan-AST(FAST)score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis : a prospective derivation and global validation study", Lancet Gastroenterol Hepatol, 5, pp.362~373 (2020)
9. Truong E, "The Agile 3+ and 4 scores most accurately predict major adverse liver outcomes and death compared to liver stiffness measurement and FibroScan-AST score", Hepatology (2022), Wiley
10. Truong E, "MRI-AST score accurately predicts major adverse liver outcome, hepatocellular carcinoma, liver transplant, and liver-related death", Clin Gastroenterol Hepatol (2023)[DOI]
11. Ajmera V, "Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease : A systematic review and meta-analysis of individual participants", Gastroenterology, 163, pp.1079~1089 (2022)
12. Younossi ZM, "the association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis", Gastroenterology, 160, pp.1608~1619 (2021)
13. Boursier J, "Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events", J Hepatol, 76, pp.1013~1020 (2022)
14. Han MAT, "MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients : A multicenter study", Liver Int, 40, pp.2242~2251 (2020)
15. Gidener T, "Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD", Clin Gastroenterol Hepatol, 19, pp.1915~1924 (2021)

관련 논문AI추천